> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel to Review Urinary Tract Infection NDA
- URL: https://www.fdaweb.com/panel-to-review-urinary-tract-infection-nda/
- Published: 2024-08-07T12:00:00.000Z
- Updated: 2026-09-14T14:37:41.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5157519

*Federal Register* notice: FDA is announcing a 9/9 Antimicrobial Drugs Advisory Committee meeting to discuss an Iterum Therapeutics NDA for oral sulopenem etzadroxil/probenecid tablets for the proposed indication of treating uncomplicated urinary tract infections caused by designated susceptible bacteria in adult women 18 years of age and older. To view the notice, click [here](https://public-inspection.federalregister.gov/2024-17642.pdf?ref=fdaweb.com).